Contact In the news Acknowledgements References Links Downloads Protocols Brainstorm Meetings

Results

Assembly of BBa_K115012 and BBa_K115029 - BBa_K115036

The first challenge of this project was to assemble all the devices we wanted to measure. An overview of these devices can be found here. For the actual construction of all devices the 3A assembly strategy was chosen. A complete protocol of this strategy can be found on OpenWetWare. A schematic representation of this assembly method is depicted in figure 1A and 1B.

Figure 1A. The mixture present in the ligation mix before it is ligated during 3A assembly. The black box indicates the CcdB 'death' gene. The arrows in red, blue and green indicate different types of antibiotic resistance. Restriction sites are indicated by: E = EcoR1; P = PstI; X = XbaI; S = SpeI. Picture taken from OpenWetWare, http://openwetware.org/wiki/Synthetic_Biology:BioBricks/3A_assembly

Figure 1B. Representation of the 3A assembly method. The black arrow indicates the CcdB gene. The arrows in other colors indicate different types of antibiotic resistance. Restriction sites are indicated by: E = EcoR1; P = PstI; X = XbaI; S = SpeI. Picture taken from OpenWetWare, http://openwetware.org/wiki/Synthetic_Biology:BioBricks/3A_assembly

For the succesful use of this assembly, it is essential that the DB3.1 Escherichia coli strain is not used as it tolerates the presence of the CcdB gene. Throughout the project we used commercial Top10 cells of Invitrogen that were made competent chemically. Furthermore, it is important to note that the XbaI and SpeI restriction enzymes generate compatible sticky ends. Assuming that we want to place two BioBrick parts behind each other in one plasmid, but these are present in seperate plasmids before assembly (as is the case in Figure 1A, parts are depicted in purple and yellow in the blue and green plasmid, respectively). 3A assembly can be conducted by taking an empty plasmid that has a different antibiotic resistence as the other two plasmids (red in figure 1A and B, CcdB is present). Three seperate restriction reactions should be started as shown in figure 1A. After cleaning up the restriction reactions they are mixed and ligated together. Parts can be ligated in several ways:

1. The CcdB gene can be ligated back in the vector - If this happens, cells will not grow after transfection, as the E. coli strain used should not be CcdB gene tolerant.
   
2. Other parts can be ligated back in the vector - Other plasmids should not have the same antibiotic resistence as the red plasmid, in other words, these are selected for.
   
3. Ligation as depicted in figure 1B - This is the ligation we are looking for and it should yield colonies after transformation.
   
4. Other combinations of backbones and/or parts - It is possible other combinations (e.g. the three backbones together) form a plasmid that yields colonies, these parts will be much larger as the ones formed in option 3. Colony PCR's are performed afterwards to screen for these.
   
   

In the end, the result on the gel of the colony PCR product is conclusive in terms of the succes of the 3A assembly. For all our parts at least three of the 3A assemblies (first promoter + ribosome binding site and luciferase + terminators, afterwards the result of these two together) gave our final product. An overview of the result on the gels can be found here. We succeeded in getting colonies that gave the correct band size on the gel for BBa_K115012 and BBa_K115029 - BBa_K115036.

Setting up luciferase measurements

Luminescence of luciferase can be measured in two strains

The first two devices that were succesfully transformed were BBa_K115012 and BBa_K115034. First we wanted an indication whether it was possible to measure luciferase using these constructs, so an experiment was set up with these two strains. The exact protocol used can be found on the 19th of September of the lab notebook. In short, sonication and lysis buffer from the Promega Luciferase kit were used to lyse the cells and luciferase expression was normalized to OD₆₀₀ of the original sample (before lysis). Furthermore, we cells were grown with and without arabinose induction as an inducible promoter (BBa_R0080) was used. Figure 3 is a graphical representation of the amount of luciferase measured for the two strains the conditions depicted.

Figure 3. Measured amount of luminescence corrected for OD, two different constructs (BBa_K115012 and BBa_K115034) were tested. Induction was achieved by adding arabinose. Sample conditions were as follows:

1. 1. Induced growth overnight at room temperature, lysis by sonication
2. 2. Induced growth overnight at 37ºC, lysis by sonication
3. 3. Induced growth two times overnight at room temperature, lysis by sonication
4. 4. Induced growth two times overnight at room temperature, lysis by Promega lysis buffer
5. 5. Non-induced growth overnight at 37ºC, lysis by sonication (no induction at all, only BBa_K115012)

Several conclusions can be drawn from figure 3, although it has to be noted that this result is only one measurement. Furthermore, room temperature was not controlled. It may have fluctuated between 20 and 27ºC. The first conclusion is that we are able to measure luciferase with these constructs. This means that all parts used work correctly, including our ribosome binding site. The second conclusion is that a differential amount of luminescence is measured between strains BBa_K115012 and BBa_K115034, although in these results we cannot see a difference that is temperature dependent. This can be seen when the bars in conditions 1 and 2 are compared, BBa_K115012 gives a larger difference in luminescence from room temperature to 37ºC than BBa_K115034. The second conclusion is that luminescence measured when lysis is performed with the provided buffer is much higher (compare bars of condition 4 to the rest). The condition measured is not optimal as room temperature is used rather than 37ºC, but even now luminescence is a multitude higher than any of the sonicated samples. The reason for this is not clear: it could be that the lysis buffer lyses cells more efficiently, alternatively it could be that sonication denaturates a large part of the luciferase in the cell. Another conclusion is that the arabinose promoter does not work; a similar amount of luminescence was measured in samples where arabinose was added as compared to non-induced samples (figure 3, compare 5 to 1, 2, and 3).

Total protein content in stead of OD measurements

To compare the amount of luciferase expression measured, the total luminescence should be normalized. In the first experiment we normalized the luminescence to the OD₆₀₀ in the culture. The OD₆₀₀ is an indication for the amount of cells present. However, the amount of protein (total protein as well as luciferase) in the sample and thus the amount of luminescence is dependent on the lysis efficiency of the method used. Correcting total luminescence for total amount of protein would circumvent the lysis efficiency. After the first experiment it was decided that total protein content measurements would be conducted in the future. The OD₆₀₀ will still be measured and lysis efficiency calculated. If a constant lysis efficiency (OD/protein content) is observed, we could still decide to normalize for OD₆₀₀.

The protocol used for the next experiment measurements can be found here. In figure 4 the results are depicted per construct in luminescence per mg of total protein. A word of caution is in order when interpreting these results, as we found out when performing BC assays (performed according to manufacturer's protocol). The lysis buffer of the Promega luciferase assay kit reacts with copper residues used to determine protein content during the BC assay. Measuring 1x lysis buffer in the BC assay give a higher read-out than any of the samples in the standard calibration curve. The results presented here are obtained by diluting the samples with lysis buffer 1,000 times so their read-out fits within a normal calibration curve, without lysis buffer. Protein content used to normalize luminescence may differ a lot from the actual protein content in the samples, but protein contents may also still be proportional.

Figure 4.